Loading…
Mankind Pharma (MANKIND)₹2,668+3.31%Pharmaceuticals
At the end of the Sep 2026 quarter, Mankind Pharma's shareholders were: promoters 72.61%, FIIs 9.34%, DIIs 15.52%, public 2.53%. Promoter holding is down 0.01 percentage points from 72.62% a quarter earlier. FII holding is down 3.46 percentage points from 12.80% a year earlier. 0.00% of promoter shares were pledged. It had 1,63,791 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 76.49% | 74.87% | 74.86% | 74.86% | 72.70% | 72.69% | 72.66% | 72.66% | 72.65% | 72.65% | 72.62% | 72.61% |
| FIIs | 6.71% | 9.84% | 11.55% | 12.34% | 13.31% | 12.89% | 13.04% | 12.80% | 11.31% | 10.21% | 9.42% | 9.34% |
| DIIs | 9.76% | 11.12% | 9.92% | 9.89% | 11.03% | 11.45% | 11.48% | 11.89% | 13.24% | 14.44% | 15.37% | 15.52% |
| Public | 7.04% | 4.17% | 3.67% | 2.91% | 2.96% | 2.97% | 2.82% | 2.65% | 2.80% | 2.70% | 2.59% | 2.53% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,27,465 | 1,35,133 | 1,53,469 | 1,63,875 | 1,71,303 | 1,80,620 | 1,79,572 | 1,70,368 | 1,77,561 | 1,77,628 | 1,66,736 | 1,63,791 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee) | Promoter | 20.22% | 0.00 |
| Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee) | Promoter | 19.31% | 0.00 |
| Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee) | Promoter | 14.99% | 0.00 |
| Sheetal Arora | Promoter | 4.65% | 0.00 |
| Puja Juneja | Promoter | 2.77% | 0.00 |
| Nps Trust- A/C Lic Pension Fund Scheme - State Gov | DII | 2.63% | New |
| Poonam Juneja | Promoter | 2.54% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Ret | DII | 2.47% | +0.39 |
| Arjun Juneja | Promoter | 1.98% | 0.00 |
| Ramesh Juneja | Promoter | 1.67% | 0.00 |
| Rajeev Juneja | Promoter | 1.56% | 0.00 |
| Sbi Esg Exclusionary Strategy Fund | DII | 1.50% | New |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla S | DII | 1.20% | New |
| Government Pension Fund Global | FII | 1.05% | −0.23 |
| Eklavya Juneja | Promoter | 0.94% | 0.00 |
| Chanakya Juneja | Promoter | 0.93% | 0.00 |
| Mishka Arora | Promoter | 0.72% | 0.00 |
| Ria Chopra Juneja | Promoter | 0.31% | 0.00 |
| Nps Trust - A/C Sbi Pension Fund Scheme - Corporat | DII | Exited | — |
| Sbi Arbitrage Opportunities Fund | DII | Exited | — |
Promoters held 72.61% of Mankind Pharma at the end of the Sep 2026 quarter, down 0.05 percentage points from 72.66% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 9.34% (down 0.08 percentage points from 9.42% a quarter earlier) and domestic institutions (DIIs) held 15.52% (up 0.15 percentage points from 15.37% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Mankind Pharma had 1,63,791 shareholders at the end of the Sep 2026 quarter, against 1,70,368 a year earlier.
Nps Trust- A/C Lic Pension Fund Scheme - State Gov (DII) held 2.63% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.